top of page

CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL

Product details

Registration number: SIN14658P

Classification: Prescription Only

Active ingredients: CEFEPIME HYDROCHLORIDE 1189 mg EQV CEFEPIME BASE

Strength: 1000MG

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route: INTRAVENOUS; INTRAMUSCULAR

Registrant: APEX PHARMA MARKETING PTE. LTD.

ATC code: J01DE01

HSA approval date: 6 November 2014

Manufacturer(s):

  • QILU PHARMACEUTICAL CO., LTD
  • QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD (Blend-Cefepime Hydrochloride (Contains Arginine))

Manufacturing country/countries: CHINA

What are the HSA registration number and classification for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14658P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: CEFEPIME HYDROCHLORIDE 1189 mg EQV CEFEPIME BASE

Strength: 1000MG

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route: INTRAVENOUS; INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: APEX PHARMA MARKETING PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • QILU PHARMACEUTICAL CO., LTD
  • QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD (Blend-Cefepime Hydrochloride (Contains Arginine))

Manufacturing country/countries: CHINA

Source for this answer

Where can I look up CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14658P or the exact product name CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14658P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page